|
1
|
Bellesoeur A, Boudou-Rouquette P, Thomas-Schoemann A, Joly C, Tlemsani C, Vidal M, Goldwasser F, Blanchet B. Individualized Pazopanib Dosing-Letter. Clin Cancer Res 2017; 23:6377. [PMID: 29030334 DOI: 10.1158/1078-0432.ccr-17-1873] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2017] [Accepted: 07/27/2017] [Indexed: 11/16/2022]
Affiliation(s)
- Audrey Bellesoeur
- Department of Medical Oncology, Hôpital Cochin, AP-HP, Paris, France.,Université Paris Descartes, Paris, France.,CARPEM, Paris, France
| | - Pascaline Boudou-Rouquette
- Department of Medical Oncology, Hôpital Cochin, AP-HP, Paris, France.,Université Paris Descartes, Paris, France.,CARPEM, Paris, France
| | - Audrey Thomas-Schoemann
- Department of Pharmacokinetics and Pharmacochemisty, Hôpital Cochin, AP-HP, Paris, France. .,CARPEM, Paris, France
| | - Charlotte Joly
- Department of Medical Oncology, Hôpital Henri Mondor, AP-HP, Paris, France
| | - Camille Tlemsani
- Department of Medical Oncology, Hôpital Cochin, AP-HP, Paris, France.,Université Paris Descartes, Paris, France.,CARPEM, Paris, France
| | - Michel Vidal
- Department of Pharmacokinetics and Pharmacochemisty, Hôpital Cochin, AP-HP, Paris, France.,CARPEM, Paris, France
| | - François Goldwasser
- Department of Medical Oncology, Hôpital Cochin, AP-HP, Paris, France.,Université Paris Descartes, Paris, France.,CARPEM, Paris, France
| | - Benoit Blanchet
- Department of Pharmacokinetics and Pharmacochemisty, Hôpital Cochin, AP-HP, Paris, France.,CARPEM, Paris, France
| |
Collapse
|